Vis enkel innførsel

dc.contributor.authorEssén, Anna
dc.contributor.authorStern, Ariel Dora
dc.contributor.authorHaase, Christoffer Bjerre
dc.contributor.authorCar, Josip
dc.contributor.authorGreaves, Felix
dc.contributor.authorPaparova, Dragana
dc.contributor.authorVandeput, Steven
dc.contributor.authorWehrens, Rik
dc.contributor.authorBates, David B.
dc.date.accessioned2023-03-30T10:37:34Z
dc.date.available2023-03-30T10:37:34Z
dc.date.created2022-03-18T13:49:01Z
dc.date.issued2022
dc.identifier.citationEssén, A., Stern, A. D., Haase, C. B., Car, J., Greaves, F., Paparova, D., Vandeput, S., Wehrens, R. & Bates, D. B. (2022). npj Digital Medicine, 5, 1-10.en_US
dc.identifier.issn2398-6352
dc.identifier.urihttps://hdl.handle.net/11250/3061091
dc.description.abstractAn abundant and growing supply of digital health applications (apps) exists in the commercial tech-sector, which can be bewildering for clinicians, patients, and payers. A growing challenge for the health care system is therefore to facilitate the identification of safe and effective apps for health care practitioners and patients to generate the most health benefit as well as guide payer coverage decisions. Nearly all developed countries are attempting to define policy frameworks to improve decision-making, patient care, and health outcomes in this context. This study compares the national policy approaches currently in development/use for health apps in nine countries. We used secondary data, combined with a detailed review of policy and regulatory documents, and interviews with key individuals and experts in the field of digital health policy to collect data about implemented and planned policies and initiatives. We found that most approaches aim for centralized pipelines for health app approvals, although some countries are adding decentralized elements. While the countries studied are taking diverse paths, there is nevertheless broad, international convergence in terms of requirements in the areas of transparency, health content, interoperability, and privacy and security. The sheer number of apps on the market in most countries represents a challenge for clinicians and patients. Our analyses of the relevant policies identified challenges in areas such as reimbursement, safety, and privacy and suggest that more regulatory work is needed in the areas of operationalization, implementation and international transferability of approvals. Cross-national efforts are needed around regulation and for countries to realize the benefits of these technologies.en_US
dc.language.isoengen_US
dc.publisherSpringer Natureen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleHealth app policy: international comparison of nine countries’ approachesen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2022 The Author(s)en_US
dc.subject.nsiVDP::Samfunnsvitenskap: 200en_US
dc.subject.nsiVDP::Samfunnsvitenskap: 200::Biblioteks- og informasjonsvitenskap: 320::Informasjons- og kommunikasjonssystemer: 321en_US
dc.source.pagenumber10en_US
dc.source.volume5en_US
dc.source.journalnpj Digital Medicineen_US
dc.identifier.doihttps://doi.org/10.1038/s41746-022-00573-1
dc.identifier.cristin2010841
dc.source.articlenumber31en_US
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal